Science 37 Holdings, Inc.

Science 37 Holdings, Inc. (Nasdaq: SNCE) is a decentralized clinical trial technology company that entered the public markets through a SPAC merger with LifeSci Acquisition Corp, sponsored by LifeSci Capital LLC, which completed its initial public offering in 2020 and closed the business combination in October 2021. Operating in the healthcare technology sector, the company develops platforms and services designed to enable remote and site-less clinical research for life sciences organizations. The company filed the referenced 8-K with the SEC on January 29, 2024, continuing its reporting obligations as a publicly listed entity. Sign up at SpacDesk for complete filing history, sponsor profiles, and deal analytics on SNCE and hundreds of other SPAC transactions.